Apollo Hospitals Board Meeting Scheduled for February 10, 2026 to Consider Q3FY26 Financial Results

Apollo Hospitals Enterprise Limited has formally notified stock exchanges about an upcoming board meeting to review its quarterly financial performance. The healthcare major will present its third-quarter results following regulatory protocols and insider trading guidelines.

Board Meeting Details

The company has scheduled its board meeting for the following parameters:

Parameter:	Details
Meeting Date:	Tuesday, February 10, 2026
Purpose:	Approval of Q3FY26 unaudited financial results
Results Period:	Three and nine months ended December 31, 2025
Format:	Standalone and Consolidated statements
Additional Matters:	Other related business items

The meeting notification was issued on January 16, 2026, and communicated to both the Bombay Stock Exchange and National Stock Exchange as per regulatory requirements under Regulation 29 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Trading Window Restrictions

In accordance with SEBI Prohibition of Insider Trading Regulations, 2015 and the company's internal code of conduct, Apollo Hospitals has implemented trading restrictions for key stakeholders. The trading window closure affects multiple categories of individuals with access to unpublished price-sensitive information.

Restriction Details:	Timeline
Window Closure Start:	January 1, 2026
Window Reopening:	February 12, 2026
Affected Parties:	Promoters, Directors, Connected Persons, Designated Employees
Duration:	Until 48 hours post-results announcement

This trading restriction ensures compliance with insider trading prevention measures and maintains market integrity during the financial results disclosure period.

Regulatory Compliance

The notification references a previous communication dated December 26, 2025, indicating the company's systematic approach to regulatory disclosures. Apollo Hospitals Enterprise Limited operates under CIN L85110TN1979PLC008035 and maintains listings on both major Indian stock exchanges with ISIN INE437A01024.

The company's structured approach to financial reporting and regulatory compliance demonstrates its commitment to transparency and adherence to market regulations. The upcoming board meeting will provide stakeholders with comprehensive insights into the company's operational and financial performance for the specified reporting period.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.51%	-2.85%	+1.89%	+0.21%	+7.88%	+188.04%

Apollo Hospitals Enterprise has announced that it will consider its third quarter financial results on February 10. This scheduled announcement represents a significant corporate milestone for the healthcare major.

Scheduled Results Announcement

The company has formally communicated the date for considering its Q3 financial results to stakeholders and market participants. This announcement provides investors and analysts with advance notice to prepare for the upcoming financial disclosure.

Event Details:	Information
Company:	Apollo Hospitals Enterprise
Event:	Q3 Results Consideration
Scheduled Date:	February 10
Quarter:	Third Quarter

Corporate Communication

The formal announcement of the results consideration date demonstrates the company's commitment to transparent corporate governance and timely financial reporting. This advance notice allows stakeholders to plan accordingly for the quarterly performance review.

Market Significance

The scheduled results consideration represents an important opportunity for investors and market participants to assess Apollo Hospitals Enterprise's quarterly performance. The announcement follows standard corporate practices for financial disclosure timing and stakeholder communication.